NFE2L2 and nervous system disorder: It was previously shown that edaravone activates the Nrf2/HO-1 pathway, exerts neuroprotective effects (including a reduction of neurological and cognitive dysfunction), and protects against cell apoptosis in mouse and rat models of various neurological disorders [39,40,41,42].